Advertisement
Organisation › Details
Biovectra Inc. (CA)
BIOVECTRA is a global biotech and pharmaceutical CDMO (contract development and manufacturing organization) that specializes in clinical-to-commercial scale production capabilities for: biologics, small molecules, bioreagents, lipids, pDNA, mRNA and LNP manufacturing and fill finish for drug products. Flexibility, creativity, process optimization and compliance are at the heart of our method. With nearly 55 years of experience and cGMP facilities in Prince Edward Island and Nova Scotia, Canada, we assure our programs advance on time and with the highest quality outcomes. *
![]() |
Start | 2024-07-22 existent |
![]() |
Industry | contract manufacturing (drugs) |
| Industry 2 | contract manufacturing (biologicals) | |
![]() |
Person | Technow, Oliver (Biovectra 202407 CEO) |
| Street | 11 Aviation Avenue | |
| City | C1E 0A1 Charlottetown, PE | |
| Tel | +1-902-566-9116 | |
| Address record changed: 2024-07-22 | ||
| Basic data | Employees | n. a. |
| Currency | USD | |
| Annual sales | 113,000,000 (revenue (2023) 2023-12-31) | |
| * Document for »About Section«: Agilent Technologies Inc.. (7/22/24). "Press Release: Agilent to Acquire North American CDMO Biovectra". Santa Clara, CA. | ||
Record changed: 2025-01-04 |
Advertisement
More documents for Agilent (Group)
- [1] Agilent Technologies Inc.. (7/29/26). "Press Release: Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo". Santa Clara, CA....
- [2] Agilent Technologies Inc.. (7/23/26). "Press Release: Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma". Santa Clara, CA....
- [3] Agilent Technologies Inc.. (7/14/26). "Press Release: Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma". Santa Clara, CA....
- [4] Agilent Technologies Inc.. (7/8/26). "Press Release: Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis". Santa Clara, CA....
- [5] Agilent Technologies Inc.. (7/1/26). "Press Release: Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight". Santa Clara, CA....
- [6] Agilent Technologies Inc.. (6/25/26). "Press Release: Agilent Completes Acquisition of Biocare Medical". Santa Clara, CA....
- [7] Agilent Technologies Inc.. (5/11/26). "Press Release: Agilent to Participate in Jefferies Global Healthcare Conference". Santa Clara, CA....
- [8] Agilent Technologies Inc.. (5/4/26). "Press Release: Agilent Names Michael Buckner as Chief Legal Officer". Santa Clara, CA....
- [9] Agilent Technologies Inc.. (4/14/26). "Press Release: Agilent Partners with OmixAI to Expand AI-Driven Proteomics in South Korea". Seoul....
- [10] Agilent Technologies Inc.. (4/2/26). "Press Release: Agilent Opens Customer Experience Center in Mumbai". Navi Mumbai....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top



![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)




![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)


